Semaglutide TFA, the trifluoroacetic acid salt form of Semaglutide. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion, thereby increasing sugar metabolism. Semaglutide, sold under the brand name Ozempic among others, is an anti-diabetic medicationused for the treatment of type 2 diabetes and chronic weight management.
|Product Name||Semaglutide TFA|
|CAS No.||910463-68-2 |
|Biological Activity||Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion.|
|Purity||Purity: ≥98% (HPLC)|
|Application||Therapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development.|
|Predicted Molecular Mass||4210.63|
|Storage||Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.|